Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (1181-1190 of 1,779) with videos related to

Pageof 178
Sort By:
Mabs|November 27, 2014
Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env proteinFrançois Curtin, Hervé Perron, Arno Kromminga, et al.
Mabs|November 27, 2014
Surrogate target cells expressing surface anti-idiotype antibody for the clinical evaluation of an internalizing CD22-specific antibodyShui-On Leung, Kai Gao, Guang Yu Wang, et al.
Mabs|October 17, 2017
Personalized medicine with biologics for severe type 2 asthma: current status and future prospectsMarie Godar, Christophe Blanchetot, Hans de Haard, et al.
Mabs|October 17, 2017
Chickens with humanized immunoglobulin genes generate antibodies with high affinity and broad epitope coverage to conserved targetsKathryn H Ching, Ellen J Collarini, Yasmina N Abdiche, et al.
Mabs|October 17, 2017
Design and characterization of MP0250, a tri-specific anti-HGF/anti-VEGF DARPin® drug candidateH Kaspar Binz, Talitha R Bakker, Douglas J Phillips, et al.
Mabs|December 12, 2017
Productive common light chain libraries yield diverse panels of high affinity bispecific antibodiesThomas Van Blarcom, Kevin Lindquist, Zea Melton, et al.
Mabs|December 23, 2017
Establishing in vitro in vivo correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokineticsLindsay B Avery, Jason Wade, Mengmeng Wang, et al.
Mabs|March 2, 2018
Automated high throughput microscale antibody purification workflows for accelerating antibody discoveryPeng Luan, Sophia Lee, Tia A Arena, et al.
Mabs|June 12, 2012
Molecular engineering of antibodies for therapeutic and diagnostic purposesFrédéric Ducancel, Bruno H Muller
Mabs|July 29, 2015
Targeting CD64 mediates elimination of M1 but not M2 macrophages in vitro and in cutaneous inflammation in mice and patient biopsiesDmitrij Hristodorov, Radoslav Mladenov, Verena von Felbert, et al.
Pageof 178

Showing results (1181-1190 of 1,779) with videos related to

Sort By:
Pageof 178
Mabs|November 27, 2014
Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env proteinFrançois Curtin, Hervé Perron, Arno Kromminga, et al.
Mabs|November 27, 2014
Surrogate target cells expressing surface anti-idiotype antibody for the clinical evaluation of an internalizing CD22-specific antibodyShui-On Leung, Kai Gao, Guang Yu Wang, et al.
Mabs|October 17, 2017
Personalized medicine with biologics for severe type 2 asthma: current status and future prospectsMarie Godar, Christophe Blanchetot, Hans de Haard, et al.
Mabs|October 17, 2017
Chickens with humanized immunoglobulin genes generate antibodies with high affinity and broad epitope coverage to conserved targetsKathryn H Ching, Ellen J Collarini, Yasmina N Abdiche, et al.
Mabs|October 17, 2017
Design and characterization of MP0250, a tri-specific anti-HGF/anti-VEGF DARPin® drug candidateH Kaspar Binz, Talitha R Bakker, Douglas J Phillips, et al.
Mabs|December 12, 2017
Productive common light chain libraries yield diverse panels of high affinity bispecific antibodiesThomas Van Blarcom, Kevin Lindquist, Zea Melton, et al.
Mabs|December 23, 2017
Establishing in vitro in vivo correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokineticsLindsay B Avery, Jason Wade, Mengmeng Wang, et al.
Mabs|March 2, 2018
Automated high throughput microscale antibody purification workflows for accelerating antibody discoveryPeng Luan, Sophia Lee, Tia A Arena, et al.
Mabs|June 12, 2012
Molecular engineering of antibodies for therapeutic and diagnostic purposesFrédéric Ducancel, Bruno H Muller
Mabs|July 29, 2015
Targeting CD64 mediates elimination of M1 but not M2 macrophages in vitro and in cutaneous inflammation in mice and patient biopsiesDmitrij Hristodorov, Radoslav Mladenov, Verena von Felbert, et al.
Pageof 178